Cocrystal Pharma appoints Douglas Mayers as Chief Medical Officer Cocrystal Pharma appoints Douglas Mayers as Chief Medical Officer While interim CEO Jeffrey Meckler takes up the position permanently Gary Baughman joins M+W Americas as Chief Operating Officer Gary Baughman joins M+W Americas as Chief Operating Officer Over the past 30 years he has worked for various technology companies leon-nanodrugs starts US operations in new York and Chicago leon-nanodrugs starts US operations in new York and Chicago Theron (Ted) Odlaug is appointed as Chief Executive Officer Crown Bioscience expands presence in France Crown Bioscience expands presence in France Severine Marrony joins the drug discovery firm as Manager, Business Development in France Dr Mary Kerr to join NeRRe Therapeutics as CEO Dr Mary Kerr to join NeRRe Therapeutics as CEO She will also become an Operating Partner at Advent Life Sciences, one of NeRRe's investors ObSeva makes two appointments ObSeva makes two appointments Elke Bestel joins as Chief Medical Officer and Jean-Pierre Gotteland as Chief Scientific Officer Abivax makes three new personnel changes Abivax makes three new personnel changes Including the appointment of a new Chief Medical Officer New Director to start at NIBSC in January 2016 New Director to start at NIBSC in January 2016 Dr Christian Schneider will replace Dr Stephen Inglis, who is retiring High Force Research makes boardroom changes following retirement of Managing Director High Force Research makes boardroom changes following retirement of Managing Director Bob Redfern co-founded the firm in 1988 PlaqueTec appoints Dr Tim Brears as CEO PlaqueTec appoints Dr Tim Brears as CEO Cambridge firm is pioneering a biomarker-based approach to understanding coronary artery disease EMD Serono appoints Scott Filosi as Senior Vice President of Managed Markets EMD Serono appoints Scott Filosi as Senior Vice President of Managed Markets Filosi brings 20 years of market access experience to the EMD Serono leadership team David Kaysen named President and CEO of Sun BioPharma David Kaysen named President and CEO of Sun BioPharma He brings more than 25 years of healthcare, commercial and public company experience to the firm Nuevolution welcomes two new faces Nuevolution welcomes two new faces Jeanette Wood joins the board as scientific advisor, while Henrik Simonsen joins the firm as Chief Financial Officer Merck reorganises Healthcare management team Merck reorganises Healthcare management team Forms a new Healthcare Executive Committee to accelerate delivery of pipeline in immuno-oncology, immunology and oncology Ian Tomlinson becomes Independent Chairman of Stevenage Bioscience Catalyst Board Ian Tomlinson becomes Independent Chairman of Stevenage Bioscience Catalyst Board Will guide open innovation campus in a phase of rapid development InMed appoints Paul Brennan as President and CEO InMed appoints Paul Brennan as President and CEO He succeeds Craig Schneider who remains on the board of directors